Drug giant Merck, which has big NC presence, to buy US biotech in $11B deal
Drug giant Merck, which has plants in the Triangle and Wilson, is expanding its reach with an $11 billion acquisition of San Diego-based Prometheus Biosciences.
Read More
immune systems
UNC researchers unravel mystery of a key to fighting autoimmune disease
UNC School of Medicine and UNC Lineberger scientists have uncovered a new molecular pathway important for the regulation of the adaptive immune system and the mitigation of autoimmune disease.
Read More
Raleigh-based biotech startup Arrevus raises $300,000
Arrevus, a Raleigh-based biotechnology company, has raised $300,000 in a private debt and options offering, according to a securities filing.
Read More
Experimental treatment uses modified stem cells to fight cancer
A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient’s own body into a powerful weapon against cancer.
Read MoreDurham-based Chimerix hands out raises, bonuses to four executives
Biopharmaceutical company Chimerix Inc. will give raises to four executive officers, including its CEO and chief medical officer, for 2018, along with bonuses for the previous year’s performance.
Read More
